Mochida Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 9.67% vs 3.11% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -10.58% vs 73.10% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32,502.00",
          "val2": "29,635.00",
          "chgp": "9.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,328.00",
          "val2": "4,200.00",
          "chgp": "-20.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.00",
          "val2": "1.00",
          "chgp": "2,800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,486.00",
          "val2": "2,780.00",
          "chgp": "-10.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "78.70%",
          "val2": "116.50%",
          "chgp": "-3.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 2.21% vs -0.36% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 25.03% vs -31.61% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105,159.00",
          "val2": "102,885.00",
          "chgp": "2.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11,067.00",
          "val2": "8,611.00",
          "chgp": "28.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "2.00",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-320.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,685.00",
          "val2": "4,547.00",
          "chgp": "25.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.30%",
          "val2": "56.40%",
          "chgp": "2.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

32,502.00

29,635.00

9.67%

Operating Profit (PBDIT) excl Other Income

3,328.00

4,200.00

-20.76%

Interest

29.00

1.00

2,800.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

2,486.00

2,780.00

-10.58%

Operating Profit Margin (Excl OI)

78.70%

116.50%

-3.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 9.67% vs 3.11% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -10.58% vs 73.10% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

105,159.00

102,885.00

2.21%

Operating Profit (PBDIT) excl Other Income

11,067.00

8,611.00

28.52%

Interest

3.00

2.00

50.00%

Exceptional Items

0.00

-320.00

100.00%

Consolidate Net Profit

5,685.00

4,547.00

25.03%

Operating Profit Margin (Excl OI)

77.30%

56.40%

2.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 2.21% vs -0.36% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 25.03% vs -31.61% in Mar 2024

All Annual Results